Maritide effects robust weight loss in people living with obesity or overweight at 52 weeks in a phase 2 study Dr. Kamal Kant Kohli30 Nov 2024 8:15 AM ISTAccording to phase 2 study, MariTide achieved significant weight loss in individuals with obesity or overweight, with up to ~20% loss in non-diabetics...
Eli Lilly's Experimental Drug Muvalaplin Lowers Inherited Cholesterol by Up to 86 percent Farhat Nasim20 Nov 2024 1:05 PM ISTRuth Gimeno, Lilly's group vice president for diabetes and metabolic research, said Eli Lilly is weighing next steps for advancing to late stage...
Alembic Pharma bags USFDA nod for Ivabradine Tablets Ruchika Sharma12 Nov 2024 4:05 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for...
Roche seeks to block Novo Nordisk's Catalent deal over weight-loss drug competition MD Bureau24 Oct 2024 2:09 PM IST"Limiting the competition in this space is not a good idea," Thomas Schinecker, CEO, Roche said.
Block Novo Holdings' USD16.5B Catalent acquisition: Consumer Groups Urge FTC over antitrust concerns MD Bureau19 Oct 2024 11:30 AM ISTThe deal could constrain options for competitors such as Amgen, Pfizer, Roche, and AstraZeneca , who are reportedly developing their own GLP 1 drugs.
Amgen plans to open new technology, innovation site in Hyderabad Ruchika Sharma10 Aug 2024 3:45 PM ISTThousand Oaks: Amgen has announced plans to open a new technology and innovation site in Hyderabad, India. The site, known as Amgen India, will...
Viatris names Corinne Le Goff as Chief Commercial Officer Ruchika Sharma16 April 2024 12:30 PM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced that Corinne Le Goff has joined the company as Chief Commercial Officer...
USFDA adds boxed warning for Amgen bone loss drug Prolia Ruchika Sharma22 Jan 2024 2:30 PM ISTNew Delhi: The U.S. Food and Drug Administration added a serious warning on the prescribing information for Amgen's drug Prolia to treat bone...
Regeneron asks US court to block Amgen Eylea biosimilar Ruchika Sharma12 Jan 2024 2:30 PM ISTThousand Oaks, California-based Amgen's proposed biosimilar would infringe 32 patents covering the manufacture and use of Eylea, Regeneron's lawsuit...
US FDA turns down full approval of Amgen lung cancer drug Lumakras Ruchika Sharma29 Dec 2023 4:30 PM ISTNew Delhi: The U.S. health regulator on Tuesday declined to grant traditional approval to Amgen's Lumakras for treating lung cancer patients with...
Glenmark Pharma bags USFDA nod for generic version of Otezla Tablets Ruchika Sharma18 Oct 2023 3:30 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. has announced that the Company has received final approval from the United States Food & Drug Administration...
Amgen settles patent lawsuit over biosimilar of JnJ's Stelara Ruchika Sharma25 May 2023 2:50 PM ISTStelara is a biologic drug, meaning it is derived from living cells and cannot be exactly duplicated.
